Copper-histidine therapy: a targeted metabolic intervention for Menkes disease. [PDF]
Batool A +5 more
europepmc +1 more source
Copper Metabolism-Related Cell Death in Kidney Diseases: Molecular Mechanisms, Disease-Specific Evidence, and Translational Implications. [PDF]
Shao W +6 more
europepmc +1 more source
Copper Homeostasis and Cuproptosis in Neurodegenerative Diseases. [PDF]
Liu B +6 more
europepmc +1 more source
ZBTB16 upregulation maintains copper homeostasis to support esophageal tumor progression. [PDF]
Wang J, Yang B, Peng S, Yang B.
europepmc +1 more source
Safety and efficacy of droxidopa for dysautonomia in adults with Menkes disease and occipital horn syndrome in the USA: a randomised phase 1/2a crossover trial. [PDF]
Kaler MM +10 more
europepmc +1 more source
Carrier-free GSH-responsive <i>in situ</i> nanoreactor for copper-overload augment cuproptosis/chemodynamic therapy. [PDF]
Hu Y +8 more
europepmc +1 more source
Nuclear accumulation of PANK4 in hippocampal astrocytes aggravates cuproptosis in association with mild cognitive impairment in aged mice. [PDF]
Wang B +15 more
europepmc +1 more source
Cuproptosis and Orthopedic Diseases: Molecular Mechanisms of Copper Metabolic Imbalance in the Skeletal System and Clinical Translation Prospects. [PDF]
Huang F, Wang J, Pan X.
europepmc +1 more source
COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function. [PDF]
Zhou Y +14 more
europepmc +1 more source
Could excessive zinc supplementation during pregnancy cause menkes disease? A hypothesis worth investigating. [PDF]
Mugundan UM, Saravanan V, Rajanandh MG.
europepmc +1 more source

